Return
Cabazitaxel
DOI:10.1038/nrd3254.png)
Abstract
En
Keywords:
RESISTANT PROSTATE-CANCER
EVERY 3 WEEKS
ANTITUMOR-ACTIVITY
PHASE-II
MULTICENTER
DOCETAXEL
TAXANE
AI Summary
Key information extracted from the uploaded paper, including a brief overview, abstract, background, key highlights, visual analysis, and future outlook.
Journal
IF:
101.8
Papers:
5.1K
Citations:
5.3W
Organization
Cited Papers
Androgen levels increase by intratumoral de novo steroidogenesis during progression of castration-resistant prostate cancer
CANCER RESEARCH
IF16.6
A multicenter phase II study of XRP6258 administered as a 1-h i.v. infusion every 3 weeks in taxane-resistant metastatic breast cancer patients
ANNALS OF ONCOLOGY
IF65.4
Maintenance of intratumoral androgens in metastatic prostate cancer: A mechanism for castration-resistant tumor growth
CANCER RESEARCH
IF16.6

